Skip to main content
Premium Trial:

Request an Annual Quote

Hannah Monds, David Dodd

Premium
Gene Express has  announced the appointment of Hannah Monds as its director of business development.
 
Prior to joining Gene Express, Monds spent more than 10 years with AAIPharma, a provider of product development and support services to the pharmaceutical, biotechnology, and medical device industries.
 

 
Private equity firm Genstar Capital, based in San Francisco, this week announced the formation of a strategic relationship with David Dodd to accelerate the company’s investment efforts in life sciences.
 
Dodd, former CEO of Serologicals and a pharmaceuticals/life sciences industry veteran, will work jointly with Harold “Bud” Ingalls, CFO, to source investment opportunities, the company said in a statement.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.